JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells

被引:103
作者
Rao, GN
Katki, KA
Madamanchi, NR
Wu, YX
Birrer, MJ
机构
[1] Univ Texas, Med Branch, Div Cardiol, Galveston, TX 77555 USA
[2] NCI, NIH, Div Canc Prevent & Control, Rockville, MD 20850 USA
关键词
D O I
10.1074/jbc.274.9.6003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To understand the role of redox-sensitive mechanisms in vascular smooth muscle cell (VSMC) growth, we have studied the effect of N-acetylcysteine (NAC), a thiol antioxidant, and diphenyleneiodonium (DPI), a potent NADH/NADPH oxidase inhibitor, on serum-, platelet-derived growth factor BB-, and thrombin-induced ERK2, JNK1, and p38 mitogen-activated protein (MAP) kinase activation; c-Fos, c-Jun, and JunB expression; and DNA synthesis. Both NAC and DPI completely inhibited agonist-induced AP-1 activity and DNA synthesis in VSMC. On the contrary, these compounds had differential effects on agonist-induced ERK2, JNK1, and p38 MAP kinase activation and c-Fos, c-Jun, and JunB expression. NAC inhibited agonist-induced ERK2, JNK1, and p38 MAP kinase activation and c-Fos, c-Jun, and JunB expression except for platelet-derived growth factor BB-induced ERK2 activation. In contrast, DPI only inhibited agonist-induced p38 MAP kinase activation and c-Fos and JunB expression. Antibody supershift assays indicated the presence of c-Fos and JunB in the AP-1 complex formed in response to all three agonists. In addition, cotransfection of VSMC with expression plasmids for c-Fos and members of the Jun family along with the AP-l-dependent reporter gene revealed that AP-1 with c-Fos and JunB composition exhibited a higher transactivating activity than AP-I with other compositions tested. All three agonists significantly stimulated reactive oxygen species production, and this effect was inhibited by both NAC and DPI. Together, these results strongly suggest a role for redox-sensitive mechanisms in agonist-induced ERK2, JNK1, and p38 MAP kinase activation; c-Fos, c-Jun, and JunB expression; AP-1 activity; and DNA synthesis in VSMC. These results also suggest a role for NADH/NADPH oxidase activity in some subset of early signaling events such as p38 MAP kinase activation and c-Fos and JunB induction, which appear to be important in agonist-induced AP-I activity and DNA synthesis in VSMC.
引用
收藏
页码:6003 / 6010
页数:8
相关论文
共 68 条
[1]   REDOX REGULATION OF FOS AND JUN DNA-BINDING ACTIVITY INVITRO [J].
ABATE, C ;
PATEL, L ;
RAUSCHER, FJ ;
CURRAN, T .
SCIENCE, 1990, 249 (4973) :1157-1161
[2]   OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922
[3]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[4]   PHORBOL ESTER INDUCIBLE GENES CONTAIN A COMMON CIS ELEMENT RECOGNIZED BY A TPA-MODULATED TRANS-ACTING FACTOR [J].
ANGEL, P ;
IMAGAWA, M ;
CHIU, R ;
STEIN, B ;
IMBRA, RJ ;
RAHMSDORF, HJ ;
JONAT, C ;
HERRLICH, P ;
KARIN, M .
CELL, 1987, 49 (06) :729-739
[5]   DIFFERENTIAL ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES BY H2O2 AND O-2(-) IN VASCULAR SMOOTH-MUSCLE CELLS [J].
BAAS, AS ;
BERK, BC .
CIRCULATION RESEARCH, 1995, 77 (01) :29-36
[6]  
BELLAVITE P, 1988, J BIOL CHEM, V263, P8210
[7]   A GROWTH FACTOR-STIMULATED AND HORMONE-STIMULATED NADH OXIDASE FROM RAT-LIVER PLASMA-MEMBRANE [J].
BRIGHTMAN, AO ;
WANG, J ;
MIU, RKM ;
SUN, IL ;
BARR, R ;
CRANE, FL ;
MORRE, DJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1105 (01) :109-117
[8]   SUPEROXIDE AND HYDROGEN-PEROXIDE IN RELATION TO MAMMALIAN-CELL PROLIFERATION [J].
BURDON, RH .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 18 (04) :775-794
[9]   INDUCTION OF C-FOS EXPRESSION THROUGH JNK-MEDIATED TCF/ELK-1 PHOSPHORYLATION [J].
CAVIGELLI, M ;
DOLFI, F ;
CLARET, FX ;
KARIN, M .
EMBO JOURNAL, 1995, 14 (23) :5957-5964
[10]  
CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1